EMPACT-MI Results: Empagliflozin After Acute Myocardial Infarction

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research - A podcast by American College of Cardiology - Tuesdays

Categories:

Education

Patients with acute myocardial infarction are at a high risk of heart failure and death. Despite advances in care and reduction in the rate of recurrent myocardial infarctions, the risk for heart failure continues to be unacceptably high. No intervention in 2 decades has been shown to improve this risk.   In this interview, Javed Butler, MD, MPH, MBA, and Sun Moon Kim, MD, FACC, discuss the results of the EMPACT-MI trial.